Elixinol Wellness Limited
ELLXF
$0.026
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.61% | 74.72% | 77.29% | 41.17% | 2.24% |
| Total Depreciation and Amortization | 15.18% | 39.10% | 73.58% | 80.76% | 87.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 635.75% | -15.24% | -86.74% | -99.10% | -109.35% |
| Change in Net Operating Assets | -258.68% | -258.68% | -258.68% | -155.85% | 965.12% |
| Cash from Operations | 37.72% | 12.78% | -25.98% | -25.03% | -22.09% |
| Capital Expenditure | 50.54% | -29.15% | -406.41% | -558.62% | -843.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -88.33% | -86.96% |
| Cash Acquisitions | 70.62% | -93.91% | -1,292.27% | -2,135.29% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.83% | 224.72% | 277.11% | 224.08% | 191.23% |
| Cash from Investing | -256.73% | 19.86% | 93.66% | 108.61% | 117.22% |
| Total Debt Issued | 653.00% | 420.00% | 187.00% | 287.00% | -- |
| Total Debt Repaid | -70.02% | -53.64% | -41.06% | -11.05% | 20.14% |
| Issuance of Common Stock | -48.01% | 16.44% | 107.07% | 73.84% | 40.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 54.18% | -25.42% | -183.42% | -140.95% | -98.49% |
| Cash from Financing | 8.32% | 59.93% | 136.30% | 111.51% | 81.44% |
| Foreign Exchange rate Adjustments | -221.15% | -236.47% | -129.33% | -116.86% | -110.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.01% | 96.55% | 117.25% | 82.03% | 63.45% |